Related Experiment Videos
Re: All-cause mortality in randomized trials of cancer screening
Journal of the National Cancer Institute
|June 6, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The analysis of cancer screening trials in which the outcome is the incidence of late-stage disease.
European journal of epidemiology·2026
Practice changing RCT design and rationale: Abbreviated MRI plus AFP vs. ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study).
JHEP reports : innovation in hepatology·2026
Factors Associated with Pediatric In-Hospital Recurrent Cardiac Arrest.
Journal of pediatric intensive care·2024
Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death.
JAMA network open·2024
Cancer rarity and mortality: Evidence from a nationwide cohort study.
Journal of the National Cancer Institute·2026
Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.
Journal of the National Cancer Institute·2026
Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.
Journal of the National Cancer Institute·2026
Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer.
Journal of the National Cancer Institute·2026
Association between genomic classifier scores and initial management of localized prostate cancer in the United States.
Journal of the National Cancer Institute·2026
Timing of mental disorders in relation to cancer-specific mortality in cancer patients.
Journal of the National Cancer Institute·2026
Subchronic kretek smoke exposure induces myocardial p53 protein expression and associated inflammatory and fibrotic alterations in rats.
Journal of advanced pharmaceutical technology & research·2026
Correction: MCL-1 as a tumor microenvironment-linked survival node in cholangiocarcinoma.
Frontiers in oncology·2026